Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 930-936-3 | CAS number: -
Carcinogenicity
Administrative data
Description of key information
Testing not required based on Column 2 of REACH Annex X.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The carcinogenic potential of the study substance is expected to be low and classification is not warranted.
Additional information
In accordance with Column 2 of REACH Annex X, a carcinogenicity study may be proposed by the registrant or may be required by the Agency in accordance with Articles 40 or 41 if: the substance has widespread dispersive use or there is evidence of frequent or long-term human exposure; and the substance has been classified as mutagen category 3 or there is evidence from the repeated dose studies that the substance is able to induce hyperplasia and/or pre-neoplastic lesions. In multiple genetic toxicity studies of the study substance, no evidence of mutagenic potential has been identified. In addition, repeated exposure to the study substance by either the oral or dermal route showed no significant treatment-related hyperplasia and/or pre-neoplastic lesions. In addition a dermal carcinogenicity study of a surrogate alkylated naphthalene material, reported no treatment-related tumors following a two year daily dietary exposure of doses up to 1500ppm. Therefore carcinogenicity testing is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
